Two veterinarians, one vision for effective use of antibiotics
Charlie Francisco, DVM, and Alex Hintz, DVM, represent two generations of veterinarians exposed to swine disease diagnosis, treatment, prevention and regulation in commercial swine operations. […]
Efficacy and safety of adjuvant compositions of a new 1-mL single-dose PCV2/M. hyopneumoniae vaccine (Circo/MycoGard®)
S. Ma1, A. Venegoni1, M. Sheeder2, M. Titus3, L. Kesl3, R. Saltzman3
1Research and Development, Pharmgate Animal Health, Wilmington, NC; 2Struve Labs, Manning, IA; 3Veterinary […]
Field safety and efficacy of a new 1-mL single-dose PCV2/M. hyopneumoniae vaccine (Circo/MycoGard ®) in pigs with severe disease conditions
D. Rosener1, A. Mueller2 , S. Ma1, R. Kaptur1
1Research and Development, Pharmgate Animal Health, Wilmington, NC; 2Swine Services Unlimited Inc., Rice, MN
Introduction
[…]
Experimental safety and efficacy of a new 1-mL single-dose PCV2/M. hyopneumoniae vaccine (Circo/MycoGard ®)
M. Baarsch1, B. Conarchy1, M. Sheeder2, R. Saltzman3
1Research and Development, Pharmgate Animal Health, Wilmington, NC; 2Struve Labs, Manning, IA; 3Veterinary Resources Inc, Ames, IA
[…]
Comparative study of the efficacy of Aivlosin® WSG versus Pulmotil® AC and Draxxin® 25 in the control of Swine Respiratory Disease (SRD)
Lechtenberg, K.F.1, Lopez, A2, Berge, A.C.3, Mora, J.2, Hintz, A. 4
1 Midwest Veterinary Services, Nebraska, U.S.; 2 […]
PCV2 VLP Vaccines Manufactured using Baculovirus Expression Systems
By Dr. Jeffrey W. Hall, Pharmgate Research Scientist
The family of viruses known as “baculovirus” infects invertebrates, with moth larvae serving as the most […]
Aivlosin® – Your First Choice for SRD and Ileitis Control
By Alexander Hintz, DVM
Tylvalosin is a newer -generation macrolide antibiotic present in both Aivlosin® 62.5% Water Soluble Granules (WSG) and Aivlosin 17% […]
Pharmgate announces new appointments.
August 10, 2012 – Pharmgate Animal Health is pleased to announce the appointment of Edward Seed as General Manager. Having started his career in South […]
Pharmgate’s parent company launches successful IPO in China
August 10, 2012 – Jinhe Biotechnology, parent of Pharmgate LLC, successfully completed an initial public offering of 27.23 million A shares of common stock […]